Global Protein Expression Market, By System Type (Prokaryotic Expression, Mammalian Cell Expression, Insect Cell Expression, Yeast Expression, Cell-Free Expression, Algal-Based Expression), Product and Service (Reagents, Expression Vectors, Competent Cells, Instruments, Services), Application (Therapeutic, Industrial, Research), End User (Pharmaceutical and Biotech Companies, Academic Research, Contract Research Organization, Others) – Industry Trends and Forecast to 2030.
Protein Expression Market Analysis and Size
The rise in the prevalence of chronic diseases is expected to drive the growth of the protein expression market during the forecast period. Furthermore, the upsurge in the demand for protein biologics is further anticipated to propel the growth of the protein expression market. Furthermore, advancements in the life science and biopharmaceutical industries are expected to support the growth of the protein expression market.
Data Bridge Market Research analyses that the protein expression market which is USD 2.50 billion in 2022, is expected to reach USD 5.85 billion by 2030, at a CAGR of 11.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Protein Expression Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
System Type (Prokaryotic Expression, Mammalian Cell Expression, Insect Cell Expression, Yeast Expression, Cell-Free Expression, Algal-Based Expression), Product and Service (Reagents, Expression Vectors, Competent Cells, Instruments, Services), Application (Therapeutic, Industrial, Research), End User (Pharmaceutical and Biotech Companies, Academic Research, Contract Research Organization, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Germany), Promega Corporation (U.S.), Thermo Fischer Scientific, Inc. (U.S.), Takara Bio Inc. (Japan), GenScript (U.S.), Lonza (Switzerland), New England Biolabs (U.S.), Oxford Expression Technology (U.K.), LifeSensors Inc. (U.S.), Proteogenix (France), Synthetic Genomics Inc. (U.S.), Peak Proteins Ltd (U.K.), Sino Biological Inc. (China), ARTES Biotechnology GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Protein expression is the process by which proteins are synthesized, regulated, and modified within a living organism. The protein expression protocol employs expression vectors, competent cells, reagents, instruments, and services. Reagents are expected to have the largest share because of the large volume used in bio-experiments. The significant growth in the protein expression industry is primarily due to increased funding for protein research from government and non-government organizations, the rising prevalence of chronic diseases, and the rising life science industry.
Protein Expression Market Dynamics
Drivers
- Rising R&D organizations
Several research organizations are utilizing microfluidic technology to profile protein expression. For instance, Cancer Research UK (CRUK) funded a study on Multiplexed single cell analysis in solid tumours using a miniaturized microfluidic assay. The increasing use of microfluidic devices for protein profiling will allow manufacturers to advance and explore the technology's opportunities.
- Rising use of E. coli bacteria
The market is expanding due to the large-scale production of a protein using E. coli bacteria, as E. coli is the most commonly used artificial expression host and is widely used because of its genomic and physiological sequencing system, which is responsible for simplifying the cloning procedure and making the E. coli host the most popular in the pharmaceutical industry. Furthermore, this process increases the binding strength of promoter region 7 and assists in transcription. Furthermore, eukaryotic expression is critical in the pharmaceutical and biotechnology industries. These factors are boosting market growth.
Opportunities
- Development of cell free techniques for protein expression
Cell-free protein expression is performed without the use of living cells, due to consumer acceptance. This technology has several advantages over other protein expression methods, and as a result, it is widely used. Cell-free protein approaches are becoming more popular due to advantages such as increased speed, the ability to express hazardous proteins, and the simplicity of amino acids from selective labelling, among other things. As a result, the novel technique has the potential to accelerate market growth.
Restraints/Challenges
- High cost of protein expression
High barriers to entry of the new organization and high cost of protein expression reagents will obstruct the market's growth rate. Limited disease awareness, high product costs, poor economic conditions, and a lack of favourable insurance systems all limit the adoption of eukaryotic expression systems products in developing regions around the world.
This protein expression market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the protein expression market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Protein Expression Market Scope
The protein expression market is segmented on the basis of system type, product and service, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
System Type
- Prokaryotic Expression
- Escherichia coli (E. coli) systems
- Others
- Mammalian Cell Expression
- Chinese hamster ovary (CHO) Systems
- Others
- Insect Cell Expression
- Baculovirus systems
- Others
- Yeast Expression
- Kluyveromyces lactic (K. lactic) systems
- Saccharomyces systems
- Others
- Cell-Free Expression
- Algal-Based Expression
Product and Service
- Reagents
- Expression Vectors
- Competent Cells
- Instruments
- Services
Application
- Therapeutic
- Industrial
- Research
End User
- Pharmaceutical and Biotech Companies
- Academic Research
- Contract Research Organization
- Others
Protein Expression Market Regional Analysis/Insights
The protein expression market is analyzed and market size insights and trends are provided by country, system type, product and service, application and end user as referenced above.
The countries covered in the protein expression market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the protein expression market due to the rise in the frequency of persistent infections. Furthermore, the growing elderly population will drive the growth of the protein expression market in the region over the forecast period.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to improving healthcare scenario in developing countries is expected to drive the region's protein expression market growth in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Protein Expression Market Share Analysis
The protein expression market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to protein expression market.
Some of the major players operating in the protein expression market are:
- Agilent Technologies, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- QIAGEN (Germany)
- Promega Corporation (U.S.)
- Thermo Fischer Scientific, Inc. (U.S.)
- Takara Bio Inc. (Japan)
- GenScript (U.S.)
- New England Biolabs (U.S.)
- Oxford Expression Technology (U.K.)
- LifeSensors Inc. (U.S.)
- Lonza (Switzerland)
- Proteogenix (France)
- Synthetic Genomics Inc. (U.S.)
- Peak Proteins Ltd (U.K.)
- Sino Biological Inc. (China)
- ARTES Biotechnology GmbH (Germany)
SKU-